Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
Top Cited Papers
- 9 April 2009
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 113 (15), 3406-3417
- https://doi.org/10.1182/blood-2008-10-167643
Abstract
As the risks of allogeneic blood transfusion (ABT)–transmitted viruses were reduced to exceedingly low levels in the US, transfusion-related acute lung injury (TRALI), hemolytic transfusion reactions (HTRs), and transfusion-associated sepsis (TAS) emerged as the leading causes of ABT-related deaths. Since 2004, preventive measures for TRALI and TAS have been implemented, but their implementation remains incomplete. Infectious causes of ABT-related deaths currently account for less than 15% of all transfusion-related mortality, but the possibility remains that a new transfusion-transmitted agent causing a fatal infectious disease may emerge in the future. Aside from these established complications of ABT, randomized controlled trials comparing recipients of non–white blood cell (WBC)–reduced versus WBC-reduced blood components in cardiac surgery have documented increased mortality in association with the use of non-WBC–reduced ABT. ABT-related mortality can thus be further reduced by universally applying the policies of avoiding prospective donors alloimmunized to WBC antigens from donating plasma products, adopting strategies to prevent HTRs, WBC-reducing components transfused to patients undergoing cardiac surgery, reducing exposure to allogeneic donors through conservative transfusion guidelines and avoidance of product pooling, and implementing pathogen-reduction technologies to address the residual risk of TAS as well as the potential risk of the next transfusion-transmitted agent to emerge in the foreseeable future.Keywords
This publication has 77 references indexed in Scilit:
- Pathogen inactivation: making decisions about new technologiesTransfusion, 2007
- The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two‐bottle culture systems and an estimation of false‐negative culture ratesTransfusion, 2007
- The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host diseaseTransfusion, 2007
- White‐blood‐cell‐containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta‐analysisVox Sanguinis, 2007
- THE EFFECTS OF LEUKOREDUCED BLOOD TRANSFUSION ON INFECTION RISK FOLLOWING INJURYShock, 2006
- Prevalence of lymphoreticular prion protein accumulation in UK tissue samplesThe Journal of Pathology, 2004
- Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgeryBMJ, 2004
- Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn traumaClinical Dermatology and Surgery, 1999
- Transfusion‐Associated Graft‐versus‐Host Disease in an Immunocompetent Patient following Cardiac SurgeryVox Sanguinis, 1999
- Diagnostic and pathogenetic considerations in transfusion‐related acute lung injuryTransfusion, 1985